Replies to post #809401 on NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

From the last 10-Q, there are 629 million potentially dilutive securities; "C" Preferred, options, warrants, convertible notes. Let's eliminate the options and warrants since those are close to 100% insider held. That leaves 218 million from Preferred and Notes.

It seems likely that a chunk of the 57 million short position is hedging related to the Preferred and Notes. That makes a hell of a lot more sense than believing all 57 million are speculative shorting of a $0.28 binary event OTC biotech.

That logic is uncomfortable two different ways for nwbo zealots:

1) It means that much of the short interest is "friendlies" hedging rather than nefarious forces.
2) It means there is no short squeeze potential. A convertible note holder can convert and deliver those shares rather than being forced to buy in the market.

[jesster64]

"There's a high likelihood of a short squeeze with positive news"
If so, it will be shortest squeeze in history. Do you think LP wouldn't dump 200 million shares into the market if SP went above $1. They still need money for everything. They are still only relying on themselves for revenue until partner is found. IMO
200 million in the bank pays for a lot of trials....

[theorysuit]

Effective OS? Did you just make that sht up? Dude there is a nothing burger 57m short interest Out of 1.7b float (that is growing by the day). There is no boogeyman short position in this stock as much as LP wants you to believe.